Tamir Miloh, MD
Department or Service
- Texas Medical Center
Associate Professor, Pediatrics
Baylor College of Medicine
Tamir Miloh, M.D. is actively involved in clinical investigation of various pediatric liver diseases such as liver transplantation, primary sclerosing cholangitis (PSC), autoimmune hepatitis, Wilson’s disease, metabolic diseases, biliary atresia, nonalcoholic fatty liver disease (NAFLD) and acute liver failure. He has a special interest in improving patient’s adherence and transition of care to adult providers. He completed a residency in Pediatrics at St Christopher’s Hospital for Children, Philadelphia with subsequent fellowship training in Pediatric Gastroenterology, Hepatology and Liver Transplant at Mount Sinai Hospital, New York. After 5 years, he established a new pediatric liver transplant program at Phoenix Children’s Hospital in collaboration with the Mayo clinic. He served as the Director of Pediatric Hepatology and Liver Transplant and was an Associate Professor at the University of Arizona and the Mayo clinic, until his recruitment to Texas Children’s Hospital and the Baylor College of Medicine in 2015. Dr. Miloh has been the primary investigator and co-investigator in numerous NIH, FDA and pharmacy initiated studies of children with chronic liver disease. He has leadership roles in Studies of Pediatric Liver Transplantation (SPLIT), North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and American Association for the Study of Liver Disease (AASLD). Dr. Miloh is invested in resident, fellow and physician education in the field of pediatric hepatology.
Dr. Miloh is also the head of the Wilson’s Disease center of excellence at Texas Children’s. He is involved in medical education and is the medical director of bariatric surgery.
|American Association for the Study of Liver Disease (AASLD)|
|American Association of Gastroenterology (AGA)|
|American Society of Transplant Surgeons (ASTS)|
|American Society of Transplantation (AST)|
|International Pediatric Transplant Association|
|North American Society of Gastroenterology and Nutrition (NASPGHAN)||Hepatology Committee|
|Studies of Pediatric Liver Transplant (SPLIT)||Research and Registry Committee|
|Wilson ’s disease medical advisory board|
Miloh T, Barton A, Wheeler J, Pham Y, Hewitt W, Keegan T, Sanchez C, Bulut P, Goss J. Immunosuppression in pediatric liver transplant recipients: Unique aspects. Liver Transplantation 2017 Feb;23(2):244-256. doi: 10.1002/lt.24677. Epub 2017 Jan 17. Review
Buness C, Lindor KD, Miloh T. Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis. Pediatric Gastroenterology, Hepatology & Nutrition 2016 Sep;19(3):210-213. Epub 2016 Sep 29.
Khan S, Schilsky M, Silber G, Morgenstern B, Miloh T. The Challenges of Diagnosing and Following Wilson Disease in the Presence of Proteinuria. Pediatric Gastroenterology, Hepatology & Nutrition 2016 Jun;19(2):139-42. doi: 10.5223/pghn.2016.19.2.139. Epub 2016 Jun 28.
Miloh T, Annunziato R, Arnon R, Warshaw J, Parkar S, Suchy F. J, Iyer K, Kerkar N. Text messaging improves adherence and reduces rejection in pediatric liver transplant recipients. Pediatrics 2009 Nov;124(5):e844-50.
Miloh T, Kerkar N, Parkar S, Annunziato R, Mendez C, Arnon R, Iyer K. Improved outcomes in pediatric liver transplantation for acute liver failure, Pediatric Transplant 2010 Nov;14(7):863-9.
Miloh T, Ravinder A, Yin W, Benedicta V.M, Kerkar N, Alonso E. Pediatric liver transplantation for sclerosing cholangitis (PSC). Liver Transplantation 2011 Aug;17(8):925-33.
Miloh T, Medical management of children after liver transplantation, Current Opinion in Organ Transplantation 2014 Oct;19(5):474-9.
Miloh T. Probiotics in Pediatric liver Disease, Journal of Clinical Gastroenterology 2015 Nov-Dec;49 Suppl 1:S33-650.